Dicerna Pharmaceuticals
DRNA
#3567
Rank
ยฃ2.36 B
Marketcap
ยฃ30.41
Share price
0.00%
Change (1 day)
17,432.65%
Change (1 year)

Revenue for Dicerna Pharmaceuticals (DRNA)

Revenue in 2021 (TTM): ยฃ0.14 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current revenue is ยฃ0.15 Billion. In 2020 the company made a revenue of ยฃ0.13 Billion an increase over the revenue in the year 2019 that were of ยฃ19.01 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dicerna Pharmaceuticals from 2017 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ0.14 B8.19%
2020ยฃ0.13 B587.36%
2019ยฃ19.01 M287.05%
2018ยฃ4.91 M171.23%
2017ยฃ1.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.82 M-98.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.82 B 31,069.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.66 B 986.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ50.26 B 32,658.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.88 B 16,770.11%๐Ÿ‡บ๐Ÿ‡ธ USA